ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko01521	EGFR tyrosine kinase inhibitor resistance	3/23	106/7206	0.004423309197
ko04012	ErbB signaling pathway	3/23	109/7206	0.00478350767973
ko04013	MAPK signaling pathway - fly	3/23	115/7206	0.00555625131516
ko01522	Endocrine resistance	3/23	124/7206	0.00684971303229
ko04014	Ras signaling pathway	4/23	279/7206	0.0108830397083
ko04270	Vascular smooth muscle contraction	3/23	154/7206	0.0123883832224
ko04330	Notch signaling pathway	2/23	62/7206	0.0164073783629
ko05224	Breast cancer	3/23	174/7206	0.017182474271
ko04072	Phospholipase D signaling pathway	3/23	197/7206	0.0238256299012
ko05214	Glioma	2/23	79/7206	0.025871413827
ko05220	Chronic myeloid leukemia	2/23	85/7206	0.029633782772
ko05218	Melanoma	2/23	85/7206	0.029633782772
ko05211	Renal cell carcinoma	2/23	96/7206	0.0370605434894
ko04650	Natural killer cell mediated cytotoxicity	2/23	97/7206	0.0377682529746
ko05034	Alcoholism	3/23	238/7206	0.038702008162
ko05100	Bacterial invasion of epithelial cells	2/23	99/7206	0.039199413262